118 related articles for article (PubMed ID: 33422578)
1. Role of community pharmacies in a population-based colorectal cancer screening program.
Vives N; Milà N; Binefa G; Travier N; Farre A; Vidal C; Sattari M; Bagaria G; Garcia M
Prev Med; 2021 Apr; 145():106420. PubMed ID: 33422578
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
[TBL] [Abstract][Full Text] [Related]
3. [Colorectal Cancer Early Screening Program of Barcelona, Spain: Indicators of the first round of a program with participation of community pharmacies].
Burón A; Grau J; Andreu M; Augé JM; Guayta-Escolies R; Barau M; Macià F; Castells A;
Med Clin (Barc); 2015 Aug; 145(4):141-6. PubMed ID: 25073826
[TBL] [Abstract][Full Text] [Related]
4. Pharmacist intervention in colorectal cancer screening initiative.
Holle LM; Levine J; Buckley T; White CM; White C; Hadfield MJ
J Am Pharm Assoc (2003); 2020; 60(4):e109-e116. PubMed ID: 32197754
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the appropriateness of a community pharmacy model for a colorectal cancer screening program in Catalonia (Spain).
Santolaya M; Aldea M; Grau J; Estrada M; Barau M; Buron A; Francesc M; Castell A; Rodriguez C; Gascón P; Rius P; Guayta-Escolies R;
J Oncol Pharm Pract; 2017 Jan; 23(1):26-32. PubMed ID: 26563130
[TBL] [Abstract][Full Text] [Related]
6. Patient perspectives on a proposed pharmacy-based colorectal cancer screening program.
Ferrari RM; Atkins DL; Wangen M; Rohweder CL; Waters AR; Correa S; Richmond J; van Rensburg D; Ittes A; Odebunmi O; Issaka RB; Ceballos R; Shah PD; Wheeler SB; Brenner AT
Transl Behav Med; 2023 Dec; 13(12):909-918. PubMed ID: 37756664
[TBL] [Abstract][Full Text] [Related]
7. "Finding the Right FIT": Rural Patient Preferences for Fecal Immunochemical Test (FIT) Characteristics.
Pham R; Cross S; Fernandez B; Corson K; Dillon K; Yackley C; Davis MM
J Am Board Fam Med; 2017; 30(5):632-644. PubMed ID: 28923816
[TBL] [Abstract][Full Text] [Related]
8. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washington State.
Kemper KE; Glaze BL; Eastman CL; Waldron RC; Hoover S; Flagg T; Tangka FKL; Subramanian S
Cancer; 2018 Nov; 124(21):4121-4129. PubMed ID: 30359468
[TBL] [Abstract][Full Text] [Related]
10. Impact of the faecal immunochemical test on colorectal cancer survival.
Gutierrez-Stampa MA; Aguilar V; Sarasqueta C; Cubiella J; Portillo I; Bujanda L
BMC Cancer; 2020 Jul; 20(1):616. PubMed ID: 32611328
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program.
Chiu HM; Chen SL; Yen AM; Chiu SY; Fann JC; Lee YC; Pan SL; Wu MS; Liao CS; Chen HH; Koong SL; Chiou ST
Cancer; 2015 Sep; 121(18):3221-9. PubMed ID: 25995082
[TBL] [Abstract][Full Text] [Related]
12. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
[TBL] [Abstract][Full Text] [Related]
13. Repeated screening for colorectal cancer with fecal occult blood test in Catalonia, Spain.
Garcia M; Borràs JM; Binefa G; Milà N; Espinàs JA; Moreno V
Eur J Cancer Prev; 2012 Jan; 21(1):42-5. PubMed ID: 21849903
[TBL] [Abstract][Full Text] [Related]
14. New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population.
Malagón M; Ramió-Pujol S; Serrano M; Amoedo J; Oliver L; Bahí A; Miquel-Cusachs JO; Ramirez M; Queralt-Moles X; Gilabert P; Saló J; Guardiola J; Piñol V; Serra-Pagès M; Castells A; Aldeguer X; Garcia-Gil LJ
PLoS One; 2020; 15(12):e0243158. PubMed ID: 33259546
[TBL] [Abstract][Full Text] [Related]
15. Individual and Geospatial Characteristics Associated With Use and Nonuse of the Fecal Immunochemical Test (FIT) for Colorectal Cancer Screening in an Urban Minority Population.
Ramai D; Etienne D; Ayide G; Fields PJ; Reddy M
J Clin Gastroenterol; 2019; 53(10):744-749. PubMed ID: 30222644
[TBL] [Abstract][Full Text] [Related]
16. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
17. Primary care provider perspectives on the role of community pharmacy in colorectal cancer screening: a qualitative study.
Brenner AT; Rohweder CL; Wangen M; Atkins DL; Ceballos RM; Correa S; Ferrari RM; Issaka RB; Ittes A; Odebunmi OO; Reuland DS; Waters AR; Wheeler SB; Shah PD
BMC Health Serv Res; 2023 Aug; 23(1):892. PubMed ID: 37612656
[TBL] [Abstract][Full Text] [Related]
18. The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening.
Kooyker AI; Toes-Zoutendijk E; Opstal-van Winden AWJ; Spaander MCW; Buskermolen M; van Vuuren HJ; Kuipers EJ; van Kemenade FJ; Ramakers C; Thomeer MGJ; Dekker E; Nagtegaal ID; de Koning HJ; van Leerdam ME; Lansdorp-Vogelaar I
Int J Cancer; 2020 Aug; 147(4):1098-1106. PubMed ID: 31853977
[TBL] [Abstract][Full Text] [Related]
19. Follow-up approaches to a health literacy intervention to increase colorectal cancer screening in rural community clinics: A randomized controlled trial.
Arnold CL; Rademaker AW; Morris JD; Ferguson LA; Wiltz G; Davis TC
Cancer; 2019 Oct; 125(20):3615-3622. PubMed ID: 31355924
[TBL] [Abstract][Full Text] [Related]
20. Improving Participation in Colorectal Cancer Screening: a Randomised Controlled Trial of Sequential Offers of Faecal then Blood Based Non-Invasive Tests.
Symonds EL; Pedersen S; Cole SR; Massolino J; Byrne D; Guy J; Backhouse P; Fraser RJ; LaPointe L; Young GP
Asian Pac J Cancer Prev; 2015; 16(18):8455-60. PubMed ID: 26745101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
